FS Development Corp. II

closed
PRDSSEC EDGARCIK: 0001822711|FS Development Holdings II, LLC•Biopharmaceutical

Capital Structure & Economics

Trust Size$100,000,000
Unit Price$10.00
Warrant Coverage-
Sponsor Promote20%

Implied Equity Architecture

Capital Allocation Baseline

Trust (100.0%)

Implied Dilution Drag

No Warrants / No Drag
Public Trust Allocation$100,000,000
Sponsor At-Risk CapitalN/A
Total Underwriting DiscountN/A
Trust Per Unit (Implied)$10.00
Sponsor Promote Allocation20%
Deal Lifecycle
IPO PricedJan 26, 2021
SearchingTarget Pending
Maturation Wall
N/A

Announced Target / M&A

  • Target CompanyPardes
  • SectorBiopharmaceutical

Board & Officers

  • Thomas G. WiggansCEO
  • Uri A. Lopatin, M.D.Director
  • Heidi HensonDirector
  • Lee D. Arnold, Ph.D.Director
  • Brian P. Kearney, PharmDDirector
  • Sean P. BruskyDirector
  • Philippe TinmouthDirector
  • Mark Auerbach(2)
    Director
  • Deborah M. AutorDirector
  • Laura J. HamillDirector
  • J. Jay LobellDirector
  • Michael D. Varney, Ph.D.Director
  • James B. Tananbaum, M.D.(2)
    Director

Advanced Structuring Terms

Target SectorsBiopharmaceutical

Syndicate & Advisors

Interactive Deal Modeling

Base financial constraints (Trust Size, Warrants, Promote) are pre-loaded into the calculation engines. Proceed to model implied dilution and advisory friction limits.

Dilution Cash Friction